115027-23-1 Usage
Uses
Used in Organic Synthesis:
4-(2-CHLOROACETYL)-1H-PYRROLE-2-CARBALDEHYDE is used as a reactive intermediate for the synthesis of various organic compounds due to its chloroacetyl and carbaldehyde functional groups, which can participate in a range of reactions such as condensation, reduction, and oxidation processes.
Used in Medicinal Chemistry:
In the pharmaceutical industry, 4-(2-CHLOROACETYL)-1H-PYRROLE-2-CARBALDEHYDE is used as a building block in the development of new drugs. Its unique structure and functional groups may contribute to the creation of novel therapeutic agents with potential applications in treating various diseases.
Used in Biological Research:
4-(2-CHLOROACETYL)-1H-PYRROLE-2-CARBALDEHYDE is utilized in biological studies to investigate its potential biological activities. Further research is necessary to understand its interactions with biological systems and its possible use as a pharmacological tool or lead compound in drug discovery.
Note: The specific applications and industries for 4-(2-CHLOROACETYL)-1H-PYRROLE-2-CARBALDEHYDE are not explicitly mentioned in the provided materials. The uses listed above are inferred based on the compound's properties and potential in organic synthesis and medicinal chemistry. Further research would be required to identify specific applications and industries.
Check Digit Verification of cas no
The CAS Registry Mumber 115027-23-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,5,0,2 and 7 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 115027-23:
(8*1)+(7*1)+(6*5)+(5*0)+(4*2)+(3*7)+(2*2)+(1*3)=81
81 % 10 = 1
So 115027-23-1 is a valid CAS Registry Number.
InChI:InChI=1/C7H6ClNO2/c8-2-7(11)5-1-6(4-10)9-3-5/h1,3-4,9H,2H2
115027-23-1Relevant articles and documents
2-guanidino-4-arylthiazoles for treatment of peptic ulcers
-
, (2008/06/13)
2-Guanidino-4-arylthiazole compounds of the formula STR1 a pharmaceutically acceptable cationic or acid addition salt thereof wherein R1 is hydrogen, (C1 -C10)alkyl, optionally substituted phenyl or certain optionally substituted aralkyl groups; R2 is hydrogen or (C1 -C4)alkyl, and Ar is certain optionally substituted pyrrolyl or indolyl groups; method for their use in treatment of gastric ulcers, by inhibition of parietal cell H+ /K+ ATPase, and antiinflammatory conditions in combination with piroxicam, for use in mammals, and pharmaceutical compositions containing said compounds.
Antiulcer Agents. 4-Substituted 2-Guanidinothiazoles: Reversible, Competitive, and Selective Inhibitors of Gastric H+,K+-ATPase
LaMattina, John L.,McCarthy, Peter A.,Reiter, Lawrence A.,Holt, William F.,Yeh, Li-An
, p. 543 - 552 (2007/10/02)
A series of 4-substituted 2-guanidinothiazoles has been found to inhibit the gastric proton-pump enzyme H+,K+-ATPase.In general, these compounds were reversible inhibitors of canine gastric H+,K+-ATPase, competi
